Watch RPRX. Know when insiders buy.
One email the day a filing lands. Free.
RPRX
Royalty Pharma plc
62.15
−0.10 −0.16%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
35
FLAG · insiders 25, shorts 44
Insiders, 90 days
−$6.3M
net selling · 0 buys, 4 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
3 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP $24.1BP/E 33.1DIV YIELD 1.46%FCF YIELD —REV TTM $2.5B +10.0%NET INCOME $815M −20.4%NET DEBT $8.1B52W 36.41 – 63.96SEC XBRL · TTM TO Invalid Date
Who holds it
| Fund | Type | Rank in portfolio | Value | Shares | As of |
|---|---|---|---|---|---|
| Renaissance Technologies | Guru | #137 | $108.5M | 1.9M | 2026-06-30 |
| Caisse de dépôt (CDPQ) | Pension | #265 | $56.3M | 1M | 2026-06-30 |
| Bridgewater Associates (Ray Dalio) | Guru | #294 | $12.3M | 220K | 2026-06-30 |
13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.
Stakes of 5% or more
No 13D or 13G filing on RPRX in the last two years from the filings we read (13G only for companies we track; the sweep began Sep 2026).
A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.